Logo Logo

Publications by Trevarthen, D.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Zinzani, P. L.; Santoro, A.; Leppa, S.; Demeter, J.; Follows, G. A.; Lenz, G.; Kim, W. S.; Mollica, L.; Nagler, A.; Diong, C. P.; Provenciio, M.; Stevens, D. A.; Trevarthen, D.; Maagnoli, M.; Cupit, L.; Yin, S.; Hiemeyer, F.; Garcia-Vargas, J.; Childs, B. H.; Dreyling, M. (2017): Efficacy and safety of Copanlisib in patients with relapsed/refractory follicular lymphoma: a subset analysis of the Chronos-1 study. In: Haematologica, Vol. 102: pp. 314-315

Dreyling, M.; Santoro, A.; Mollica, L.; Leppa, S.; Follows, G. A.; Lenz, G.; Kim, W. S.; Nagler, A.; Panayiotidis, P.; Demeter, J.; Ozcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Stevens, D. A.; Trevarthen, D.; Giurescu, M.; Kupit, L.; Childs, B. H.; Zinzani, P. L. (2017): Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study. In: Oncology Research and Treatment, Vol. 40: p. 12

This list was generated on Sat Sep 26 00:41:24 2020 CEST.